Clinical Trial Update: Nivolumab, Fluorouracil, and Interferon Alpha 2B for the Treatment of Unresectable Fibrolamellar Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for a combination of nivolumab, fluorouracil, and interferon alfa-2b in unresectable fibrolamellar hepatocellular carcinoma (Phase 1/Phase…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fibrolamellar Hepatocellular Carcinoma
• Hepatocellular Carcinoma

Drugs mentioned

• FLUOROURACIL (Fluorouracil)
• Interferon alfa-2b (interferon alfa-2b)
• nivolumab (nivolumab)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Stage III Hepatocellular Carcinoma AJCC v8, Stage IIIA Hepatocellular Carcinoma AJCC v8 | Phase 1, Phase 2 | Status: RECRUITING